Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria J Findlay

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Neoplasia (New York, N.Y.)|May 31, 2015
Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironmentLindsay T McDonald, Dayvia L Russell, Ryan R Kelly, et al.
Breast Cancer Research : BCR|October 6, 2023
Pubertal exposure to dietary advanced glycation end products disrupts ductal morphogenesis and induces atypical hyperplasia in the mammary glandBradley A Krisanits, Reid Schuster, Jaime Randise, et al.
Journal of Medicinal Chemistry|February 3, 2006
PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activityJoseph E Saavedra, Aloka Srinivasan, Gregory S Buzard, et al.
Translational Oncology|January 29, 2022
Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblastsBradley A Krisanits, Pamela Woods, Lourdes M Nogueira, et al.
Advances in Cancer Research|April 4, 2020
BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivorsMarvella E Ford, Colleen E Bauza, Victoria J Findlay, et al.
Frontiers in Immunology|January 26, 2026
Making deep immunophenotyping accessible: the successful application of a guided 23-parameter mouse immunophenotyping panel package provided through a shared resourceMadison G Isbell, Alex Wendling, Xinyan Pei, et al.
Breast Cancer Research and Treatment|October 29, 2018
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle interventionKatherine R Walter, Marvella E Ford, Mathew J Gregoski, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Neoplasia (New York, N.Y.)|May 31, 2015
Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironmentLindsay T McDonald, Dayvia L Russell, Ryan R Kelly, et al.
Breast Cancer Research : BCR|October 6, 2023
Pubertal exposure to dietary advanced glycation end products disrupts ductal morphogenesis and induces atypical hyperplasia in the mammary glandBradley A Krisanits, Reid Schuster, Jaime Randise, et al.
Journal of Medicinal Chemistry|February 3, 2006
PABA/NO as an anticancer lead: analogue synthesis, structure revision, solution chemistry, reactivity toward glutathione, and in vitro activityJoseph E Saavedra, Aloka Srinivasan, Gregory S Buzard, et al.
Translational Oncology|January 29, 2022
Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblastsBradley A Krisanits, Pamela Woods, Lourdes M Nogueira, et al.
Advances in Cancer Research|April 4, 2020
BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivorsMarvella E Ford, Colleen E Bauza, Victoria J Findlay, et al.
Frontiers in Immunology|January 26, 2026
Making deep immunophenotyping accessible: the successful application of a guided 23-parameter mouse immunophenotyping panel package provided through a shared resourceMadison G Isbell, Alex Wendling, Xinyan Pei, et al.
Breast Cancer Research and Treatment|October 29, 2018
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle interventionKatherine R Walter, Marvella E Ford, Mathew J Gregoski, et al.
Pageof 4